Titilope Fasipe, MD, PhD: Plenary Speaker at NORD Summit

Video

As the opening plenary speaker at the National Organization for Rare Disease summit, Dr. Fasipe shares from her unique perspective as doctor and patient of sickle cell disease.

Titilope Fasipe, MD, PhD, Assistant Professor of Pediatric Hematology-Oncology, Baylor College of Medicine, was invited to be the opening plenary speaker at the National Organization for Rare Disease (NORD) summit.

Traditionally, the position of the opening plenary speaker has gone to individuals who shared personal experiences with a rare disease. Fasipe has a unique perspective as a patient and a doctor of sickle cell disease.

In her talk, Fasipe mentions the importance of successful partnerships. It's not uncommon for a patient of rare disease to feel isolated or alone in their experience.

"There's not enough awareness about them in the community," Fasipe said about rare diseases, "even the medical community."

When people or organizations partner together, it can make all the difference. Whether it's healthcare institutions, government agencies, or even local community based organizations, there's strength in working together.

"At the end of the day the goal is to bring exposure and light to that disease and the most important part is to improve the outcome, the quality of life of the people who have that disease," Fasipe explained. "Just because your disease affects less people in the country does not make it less important."

Related Videos
Signs and Symptoms of Connective Tissue Disease
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
Danielle O'Laughlin, PA-C, MS: Navigating Long-Term Risks, Family Planning in PCOS
Elna Saah, MD: Unraveling the Current Landscape of Sickle Cell Disease | Image Credit: Twitter
Hematopoietic Stem Cell Transplantation Improves Pediatric SCD Outcomes | Image Credit: Scott Graham/Unsplash
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
How Gene and Cell Therapy Is Developing in Dermatology
Joyce Teng, MD, PhD, discusses how therapeutic advances in fields like epidermolysis bullosa should progress treatment discourse in other rare dermatoses.
The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD
© 2024 MJH Life Sciences

All rights reserved.